医药行业分析
- (2021-12-30)
- (2021-12-30)
- (2021-12-30)
- (2021-12-30)
- (2021-12-30)
- (2021-12-30)
- (2021-12-30)
- (2021-12-30)
- (2021-12-29)
- (2021-12-29)
- (2021-12-29)
- (2021-12-29)
- (2021-12-29)
- (2021-12-28)
- (2021-12-28)
- (2021-12-28)
- (2021-12-28)
- (2021-12-28)
- (2021-12-28)
- (2021-12-28)
- (2021-12-27)
- (2021-12-27)
- (2021-12-27)
- (2021-12-27)
- (2021-12-27)
- (2021-12-27)
- (2021-12-27)
- (2021-12-27)
- (2021-12-27)
告别白血病化疗(CLL)!Imbruvica Venclexta一线固定疗程:在苯丁酸氮芥方面优于obinutuzumab方案!
(2021-12-27)- (2021-12-27)
- (2021-12-27)
- (2021-12-27)
- (2021-12-25)
- (2021-12-25)
- (2021-12-25)
- (2021-12-24)
- (2021-12-23)
- (2021-12-23)
- (2021-12-23)
- (2021-12-23)
- (2021-12-23)
欧盟扩大了gülid Veklury(Remdesivir)的适应症:治疗不需要补充氧气 发展为严重COVID的风险很高
(2021-12-23)- (2021-12-23)
- (2021-12-23)
- (2021-12-22)
- (2021-12-22)
- (2021-12-22)
- (2021-12-22)
- (2021-12-22)
- (2021-12-22)
- (2021-12-21)
- (2021-12-21)
- (2021-12-21)
- (2021-12-21)
- (2021-12-20)
- (2021-12-20)
- (2021-12-20)
- (2021-12-20)
- (2021-12-20)